BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xie Y, Tan Y, Yang C, Zhang X, Xu C, Qiao X, Xu J, Tian S, Fang C, Kang C. Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis. Cancer Biol Med 2019;16:784-96. [PMID: 31908895 DOI: 10.20892/j.issn.2095-3941.2019.0143] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
Number Citing Articles
1 Zhang K, Zhao H, Zhang K, Hua C, Qin X, Xu S. Chromatin-regulating genes are associated with postoperative prognosis and isocitrate dehydrogenase mutation in astrocytoma. Ann Transl Med 2020;8:1594. [PMID: 33437793 DOI: 10.21037/atm-20-7229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Brondani VB, Lacombe AMF, Mariani BMP, Montenegro L, Soares IC, Bezerra-Neto JE, Tanno FY, Srougi V, Chambo JL, Mendonca BB, Almeida MQ, Zerbini MCN, Fragoso MCBV. Low Protein Expression of both ATRX and ZNRF3 as Novel Negative Prognostic Markers of Adult Adrenocortical Carcinoma. Int J Mol Sci 2021;22:1238. [PMID: 33513905 DOI: 10.3390/ijms22031238] [Reference Citation Analysis]
3 Sun P, Xiao Y, Di Q, Ma W, Ma X, Wang Q, Chen W. Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme. Int J Nanomedicine 2020;15:6673-88. [PMID: 32982226 DOI: 10.2147/IJN.S257459] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
4 Xie Y, Wang H, Wang S, Feng Y, Feng Y, Fan S, Hu C, Liu X, Hou T. Clinicopathological Significance of ATRX Expression in Nasopharyngeal Carcinoma Patients: A Retrospective Study. J Cancer 2021;12:6931-6. [PMID: 34729095 DOI: 10.7150/jca.63333] [Reference Citation Analysis]
5 Zhang H, Luo YB, Wu W, Zhang L, Wang Z, Dai Z, Feng S, Cao H, Cheng Q, Liu Z. The molecular feature of macrophages in tumor immune microenvironment of glioma patients. Comput Struct Biotechnol J 2021;19:4603-18. [PMID: 34471502 DOI: 10.1016/j.csbj.2021.08.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Dumke R, Dumke C, Eberle F, Nimsky C, Keber U, Engenhart-Cabillic R, Lautenschläger S. Monocentric evaluation of Ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy. Strahlenther Onkol 2022. [PMID: 35612598 DOI: 10.1007/s00066-022-01959-6] [Reference Citation Analysis]
7 Zhang N, Dai Z, Wu W, Wang Z, Cao H, Zhang Y, Wang Z, Zhang H, Cheng Q. The Predictive Value of Monocytes in Immune Microenvironment and Prognosis of Glioma Patients Based on Machine Learning. Front Immunol 2021;12:656541. [PMID: 33959130 DOI: 10.3389/fimmu.2021.656541] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
8 Zhou K, Liu Y, Zhao Z, Wang Y, Huang L, Chai R, Li G, Jiang T. ABCC8 mRNA expression is an independent prognostic factor for glioma and can predict chemosensitivity. Sci Rep 2020;10:12682. [PMID: 32728190 DOI: 10.1038/s41598-020-69676-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zhou C, Zhao H, Yang F, Huangfu L, Dong C, Wang S, Zhang J. Clinical and Genetic Features of Brainstem Glioma in Adults: A Report of 50 Cases in a Single Center. J Clin Neurol 2021;17:220-8. [PMID: 33835742 DOI: 10.3988/jcn.2021.17.2.220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hou T, Jiang S, Wang Y, Xie Y, Zhang H, Feng Y, Ma F, Ma J, Liu X, Hu C. Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors. Front Oncol 2020;10:608300. [PMID: 33409155 DOI: 10.3389/fonc.2020.608300] [Cited by in F6Publishing: 1] [Reference Citation Analysis]